Literature DB >> 4331158

Benefit from alternate-day prednisone in myasthenia gravis.

J R Warmolts, W K Engel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4331158     DOI: 10.1056/NEJM197201062860104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  A system for evaluating and classifying data in family practice.

Authors:  O F Mixa
Journal:  Can Fam Physician       Date:  1974-11       Impact factor: 3.275

2.  Myasthenia gravis.

Authors:  N Vijayan; P M Dreyfus
Journal:  Calif Med       Date:  1972-11

3.  Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis.

Authors:  N Wakata; Y Kawamura; M Kobayashi; Y Araki; M Kinoshita
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

4.  Steroid therapy of myasthenia gravis.

Authors:  N Vijayan; P M Dreyfus
Journal:  West J Med       Date:  1975-08

5.  Effects of alternate-day prednisone therapy on respiratory function in myasthenia gravis.

Authors:  H H Newball; S A Brahim
Journal:  Thorax       Date:  1976-08       Impact factor: 9.139

6.  The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.

Authors:  F J Frey; M K Rüegsegger; B M Frey
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

7.  Myasthenia gravis.

Authors: 
Journal:  West J Med       Date:  1979-05

Review 8.  Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.

Authors:  Yan Luo; Deng-Ji Pan; Fei-Fei Chen; Ming-Hui Zhu; Jing Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

9.  Surgical treatment for myasthenia gravis.

Authors:  T J Otto; H Strugalska
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

10.  Immune regulation of experimental myasthenia.

Authors:  S Fuchs; D Bartfeld; Z Eshhar; C Feingold; D Mochly-Rosen; D Novick; M Schwartz; R Tarrab-Hazdai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.